PRP therapy uses the patients own blood, which eliminates the risk of allergic reaction or disease transmission
Many find diet and exercise alone insufficient in tackling weight issues
Though retatrutide is not yet FDA approved , the phase III clinical trial of this weight loss injection is currently underway, which means you can expect it to receive FDA approval sometime in 2026 or 2027
a phenomenon characterised by an irreversible cessation in the division of normal cells
The CREDENCE trial enrolled 4,401 participants with type 2 diabetes mellitus and CKD, with a mean eGFR of 56.2 mL/min/1.73 m 2 and a median urinary albumin-to-creatinine ratio (UACR) of 927 mg/g (Table 1, Fig
Studies indicate that diminished VEGF expression precipitates neurodegeneration by compromising neural tissue perfusion, thus exacerbating neuronal vulnerability to ischemic insults and metabolic imbalances (Oosthuyse et al